Kymera Therapeutics, Inc. ($KYMR)
Filing Information
| Accession Number | 0001193125-26-383874 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 4, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
6,371
Total Value
$744,297.29
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Legal Officer | Common Stock | โ | Sep 4, 2026 | Sale | 1,209 | $115.55 | $139,699.95 | 55,416 | Direct | โ | View Details | |
Chief Legal Officer | Common Stock | โ | Sep 4, 2026 | Sale | 3,025 | $116.81 | $353,350.25 | 52,391 | Direct | โ | View Details | |
Chief Legal Officer | Common Stock | โ | Sep 4, 2026 | Sale | 2,137 | $117.57 | $251,247.09 | 50,254 | Direct | โ | View Details |